Patient:
Female, 56years old, 165.5lbs

On december 1st, the patient started therapy with desloratadine(AERIUS)tablet, oral, 5.0 mg, 1 every 1 day and used for unknown indication. On december 20th, the patient experienced hallucination, auditory, psychotic disorder and paranoia.    

The action taken with suspect products was unknown.
The outcome of hallucination, auditory, psychotic disorder and paranoia was recovered on an unspecified date. 

Relatedness between the suspect therapies and the events: hallucination, auditory, psychotic disorder and paranoia was not reported.

The agency considered the events to be medically significant.     

Additional information is not expected due to agency confidentiality clause.